Advertisement

Vulvar Disease pp 289-298 | Cite as

Immune Blistering Disorders

  • Sarah Shaffer
  • Colleen K. StockdaleEmail author
Chapter

Abstract

Immune blistering diseases may involve the cutaneous or mucosal surfaces of the female genital structures. Blisters that form on mucosal surfaces erode quickly and appear more commonly as erosions. Diagnosis requires a thorough history and full examination of all cutaneous and mucosal sites to identify lesions that may be asymptomatic, healing, or hidden from view. Histology and direct immunofluorescence of a biopsy taken from the edge of a blister or erosion are necessary to diagnose and differentiate these diseases. An important characteristic is the location of blister formation: subepidermal or intraepidermal.

Management principles and recommended medications overlap for many of the immune blistering diseases; where specific differences exist, notations are made with the description of the disease. Systemic steroids or other immune-suppressive medication are often indicated. The use of topical steroids is occasionally sufficient and should be considered for vulvar skin lesions, especially in disease that is otherwise well-controlled. General care of the vulvar skin should include a review of basic guidelines with emphasis on soaks and barriers or skin protectants. Close follow-up and examination of cutaneous and mucosal surfaces are warranted for surveillance as many of these diseases are prone to recur.

References

  1. 1.
    Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381(9863):320–32.PubMedGoogle Scholar
  2. 2.
    Bifulco G, Mandato VD, Piccoli R, Giampaolino P, Mignogna C, Mignogna MD, et al. Early invasive vulvar squamous cell carcinoma arising in a woman with vulvar pemphigus vulgaris and systemic lupus erythematosus. BMC Cancer. 2010;10:324.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Goldstein AT, Anhalt GJ, Klingman D, Burrows LJ. Mucous membrane pemphigoid of the vulva. Obstet Gynecol. 2005;105(5 Pt 2):1188–90.PubMedGoogle Scholar
  4. 4.
    Huilaja L, Makikallio K, Hannula-Jouppi K, Vakeva L, Hook-Nikanne J, Tasanen K. Cyclosporine treatment in severe gestational pemphigoid. Acta Derm Venereol. 2015;95(5):593–5.PubMedGoogle Scholar
  5. 5.
    Malakar S, Saha A. Successful treatment of resistant Lichen Planus Pemphigoides with cyclosporine: a new hope. Indian J Dermatol. 2016;61(1):112–4.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Investig Dermatol. 2015;8:257–65.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Contestable JJ, Edhegard KD, Meyerle JH. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Am J Clin Dermatol. 2014;15(6):517–24.PubMedGoogle Scholar
  8. 8.
    Barbosa WS, Rodarte CM, Guerra JG, Maciel VG, Fleury Junior LF, Costa MB. Bullous systemic lupus erythematosus: differential diagnosis with dermatitis herpetiformis. An Bras Dermatol. 2011;86(4 Suppl 1):S92–5.PubMedGoogle Scholar
  9. 9.
    Lebeau S, Mainetti C, Masouye I, Saurat JH, Borradori L. Localized childhood vulval pemphigoid treated with tacrolimus ointment. Dermatology. 2004;208(3):273–5.PubMedGoogle Scholar
  10. 10.
    Gunther C, Wozel G, Meurer M, Pfeiffer C. Topical tacrolimus treatment for cicatricial pemphigoid. J Am Acad Dermatol. 2004;50(2):325–6.PubMedGoogle Scholar
  11. 11.
    Howell E, Johnson SM. Venous thrombosis occurring after initiation of thalidomide for the treatment of cicatricial pemphigoid. J Drugs Dermatol. 2004;3(1):83–5.PubMedGoogle Scholar
  12. 12.
    Nguyen T, Alraqum E, Razzaque Ahmed A. Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis. Int Immunopharmacol. 2015;26(1):1–3.PubMedGoogle Scholar
  13. 13.
    Pipkin C. Erosive diseases of the vulva. Dermatol Clin. 2010;28(4):737–51.PubMedGoogle Scholar
  14. 14.
    Lebeau S, Braun RP, Masouye I, Perrinaud A, Harms M, Borradori L. Acquired melanocytic naevus in childhood vulval pemphigoid. Dermatology. 2006;213(2):159–62.PubMedGoogle Scholar
  15. 15.
    Urano S. Localized bullous pemphigoid of the vulva. J Dermatol. 1996;23(8):580–2.PubMedGoogle Scholar
  16. 16.
    Levine V, Sanchez M, Nestor M. Localized vulvar pemphigoid in a child misdiagnosed as sexual abuse. Arch Dermatol. 1992;128(6):804–6.PubMedGoogle Scholar
  17. 17.
    Stage AH, Humeniuk JM, Easley WK. Bullous pemphigoid of the vulva: a case report. Am J Obstet Gynecol. 1984;150(2):169–70.PubMedGoogle Scholar
  18. 18.
    Ridley CM. Cicatricial pemphigoid of the vulva. Am J Obstet Gynecol. 1985;152(7 Pt 1):916–7.PubMedGoogle Scholar
  19. 19.
    Leonard N, Biswas A, Hickey S, Bell H. Eosinophilic spongiosis in a case of lichen sclerosus: a marker for superimposed bullous pemphigoid? Histopathology. 2008;52(7):885–7.PubMedGoogle Scholar
  20. 20.
    Farrell AM, Kirtschig G, Dalziel KL, Allen J, Dootson G, Edwards S, et al. Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol. 1999;140(2):308–12.PubMedGoogle Scholar
  21. 21.
    Marren P, Wojnarowska F, Venning V, Wilson C, Nayar M. Vulvar involvement in autoimmune bullous diseases. J Reprod Med. 1993;38(2):101–7.PubMedGoogle Scholar
  22. 22.
    Wojnarowska F, Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988;19(5 Pt 1):792–805.PubMedGoogle Scholar
  23. 23.
    Edwards S, Wojnarowska F, Armstrong LM. Chronic bullous disease of childhood with oral mucosal scarring. Clin Exp Dermatol. 1991;16(1):41–3.PubMedGoogle Scholar
  24. 24.
    Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138(3):370–9.PubMedGoogle Scholar
  25. 25.
    Edwards L, Hays S. Vulvar cicatricial pemphigoid as a lichen sclerosus imitator. A case report. J Reprod Med. 1992;37(6):561–4.PubMedGoogle Scholar
  26. 26.
    Marren P, Walkden V, Mallon E, Wojnarowska F. Vulval cicatricial pemphigoid may mimic lichen sclerosus. Br J Dermatol. 1996;134(3):522–4.PubMedGoogle Scholar
  27. 27.
    Hoque SR, Patel M, Farrell AM. Childhood cicatricial pemphigoid confined to the vulva. Clinical. Dermatology. 2005;31:63–4.Google Scholar
  28. 28.
    Sadik CD, Lima AL, Zillikens D. Pemphigoid gestationis: toward a better understanding of the etiopathogenesis. Clin Dermatol. 2016;34(3):378–82.PubMedGoogle Scholar
  29. 29.
    Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol. 1999;24(4):255–9.PubMedGoogle Scholar
  30. 30.
    Chi CC, Wang SH, Charles-Holmes R, Ambros-Rudolph C, Powell J, Jenkins R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol. 2009;160(6):1222–8.PubMedGoogle Scholar
  31. 31.
    Sitaru C, Powell J, Messer G, Brocker EB, Wojnarowska F, Zillikens D. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol. 2004;103(4):757–63.PubMedGoogle Scholar
  32. 32.
    Zaraa I, Mahfoudh A, Sellami MK, Chelly I, El Euch D, Zitouna M, et al. Lichen planus pemphigoides: four new cases and a review of the literature. Int J Dermatol. 2013;52(4):406–12.PubMedGoogle Scholar
  33. 33.
    Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Camisa C. Vesiculobullous systemic lupus erythematosus. A report of four cases. J Am Acad Dermatol. 1988;18(1 Pt 1):93–100.PubMedGoogle Scholar
  35. 35.
    Miziara ID, Mahmoud A, Chagury AA, Alves RD. Bullous systemic lupus Erythematosus: case report. Int Arch Otorhinolaryngol. 2013;17(3):344–6.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Pinto-Sanchez MI, Bercik P, Verdu EF, Bai JC. Extraintestinal manifestations of celiac disease. Dig Dis. 2015;33(2):147–54.PubMedGoogle Scholar
  37. 37.
    Malik M, Ahmed AR. Involvement of the female genital tract in pemphigus vulgaris. Obstet Gynecol. 2005;106(5 Pt 1):1005–12.PubMedGoogle Scholar
  38. 38.
    Lopez-Jornet P, Bermejo-Fenoll A. Gingival lesions as a first symptom of pemphigus vulgaris in pregnancy. Br Dent J. 2005;199(2):91–2.PubMedGoogle Scholar
  39. 39.
    Fairbanks Barbosa ND, de Aguiar LM, Maruta CW, Aoki V, Sotto MN, Labinas GH, et al. Vulvo-cervico-vaginal manifestations and evaluation of Papanicolaou smears in pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol. 2012;67(3):409–16.PubMedGoogle Scholar
  40. 40.
    Kavala M, Topaloglu Demir F, Zindanci I, Can B, Turkoglu Z, Zemheri E, et al. Genital involvement in pemphigus vulgaris (PV): correlation with clinical and cervicovaginal pap smear findings. J Am Acad Dermatol. 2015;73(4):655–9.PubMedGoogle Scholar
  41. 41.
    Batta K, Munday PE, Tatnall FM. Pemphigus vulgaris localized to the vagina presenting as chronic vaginal discharge. Br J Dermatol. 1999;140(5):945–7.PubMedGoogle Scholar
  42. 42.
    Wieselthier JS, Pincus SH. Hailey-Hailey disease of the vulva. Arch Dermatol. 1993;129(10):1344–5.PubMedGoogle Scholar
  43. 43.
    de Jesus LE, Dekermacher S, Manhaes CR, Faria LM, Barros ML. Acquired labial sinechiae and hydrocolpos secondary to Stevens-Johnson syndrome. Urology. 2012;80(4):919–21.PubMedGoogle Scholar
  44. 44.
    Ting HC, Adam BA. Stevens-Johnson syndrome. A review of 34 cases. Int J Dermatol. 1985;24(9):587–91.PubMedGoogle Scholar
  45. 45.
    Wain EM, Neill S. Fixed drug eruption of the vulva secondary to fluconazole. Clin Exp Dermatol. 2008;33(6):784–5.PubMedGoogle Scholar
  46. 46.
    Fischer G. Vulvar fixed drug eruption. A report of 13 cases. J Reprod Med. 2007;52(2):81–6.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyUniversity of IowaIowa CityUSA

Personalised recommendations